array:24 [
  "pii" => "S1579212917301349"
  "issn" => "15792129"
  "doi" => "10.1016/j.arbr.2017.01.018"
  "estado" => "S300"
  "fechaPublicacion" => "2017-05-01"
  "aid" => "1563"
  "copyright" => "SEPAR"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "Arch Bronconeumol. 2017;53:235-6"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 1013
    "formatos" => array:3 [
      "EPUB" => 140
      "HTML" => 548
      "PDF" => 325
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0300289617300418"
      "issn" => "03002896"
      "doi" => "10.1016/j.arbres.2017.01.016"
      "estado" => "S300"
      "fechaPublicacion" => "2017-05-01"
      "aid" => "1563"
      "copyright" => "SEPAR"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "sco"
      "cita" => "Arch Bronconeumol. 2017;53:235-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2193
        "formatos" => array:3 [
          "EPUB" => 154
          "HTML" => 1479
          "PDF" => 560
        ]
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "Novelties in the Treatment of Pulmonary Hypertension"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "235"
            "paginaFinal" => "236"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Novedades en el tratamiento de la hipertensi&#243;n pulmonar"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Jason Weatherald, Yu Taniguchi, Marc Humbert"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Jason"
                "apellidos" => "Weatherald"
              ]
              1 => array:2 [
                "nombre" => "Yu"
                "apellidos" => "Taniguchi"
              ]
              2 => array:2 [
                "nombre" => "Marc"
                "apellidos" => "Humbert"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1579212917301349"
          "doi" => "10.1016/j.arbr.2017.01.018"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301349?idApp=UINPBA00003Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617300418?idApp=UINPBA00003Z"
      "url" => "/03002896/0000005300000005/v1_201704280943/S0300289617300418/v1_201704280943/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1579212917300058"
    "issn" => "15792129"
    "doi" => "10.1016/j.arbr.2017.01.002"
    "estado" => "S300"
    "fechaPublicacion" => "2017-05-01"
    "aid" => "1525"
    "copyright" => "SEPAR"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Arch Bronconeumol. 2017;53:237-44"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 2730
      "formatos" => array:3 [
        "EPUB" => 153
        "HTML" => 1929
        "PDF" => 648
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Changes in Ventilatory Response to Exercise in Trained Athletes&#58; Respiratory Physiological Benefits Beyond Cardiovascular Performance"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "237"
          "paginaFinal" => "244"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Cambios en la respuesta ventilatoria al esfuerzo en deportistas entrenados&#58; efectos beneficiosos sobre la fisiolog&#237;a respiratoria m&#225;s all&#225; del rendimiento cardiovascular"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Fig&#46; 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 1197
              "Ancho" => 1578
              "Tamanyo" => 73205
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Tidal volume &#40;V<span class="elsevierStyleInf">T</span>&#41; is plotted as a function of ventilation &#40;V<span class="elsevierStyleInf">E</span>&#41; in response to symptom-limited treadmill exercise in all study subjects before &#40;filled circles&#41; and after &#40;open circles&#41; 8 months of training and competition&#46; The graph shows mean values at baseline &#40;starting at 8<span class="elsevierStyleHsp" style=""></span>km&#47;h&#41;&#44; iso-speed &#40;16<span class="elsevierStyleHsp" style=""></span>km&#47;h&#41;&#44; V<span class="elsevierStyleInf">T</span>&#47;V<span class="elsevierStyleInf">E</span> inflection 1&#44; V<span class="elsevierStyleInf">T</span>&#47;V<span class="elsevierStyleInf">E</span> inflection 2 and peak exercise&#46; <span class="elsevierStyleItalic">P</span> values before vs after training and competition at the same measurement point are shown in <a class="elsevierStyleCrossRefs" href="#tbl0010">Tables 2 and 3</a>&#46; <span class="elsevierStyleItalic">Abbreviations</span>&#58; L&#44; liters&#59; min&#44; minutes&#59; km&#44; kilometers&#59; h&#44; hours&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Adriano Di Paco, Bruno-Pierre Dub&#233;, Pierantonio Laveneziana"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Adriano"
              "apellidos" => "Di Paco"
            ]
            1 => array:2 [
              "nombre" => "Bruno-Pierre"
              "apellidos" => "Dub&#233;"
            ]
            2 => array:2 [
              "nombre" => "Pierantonio"
              "apellidos" => "Laveneziana"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0300289616303556"
        "doi" => "10.1016/j.arbres.2016.11.023"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616303556?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917300058?idApp=UINPBA00003Z"
    "url" => "/15792129/0000005300000005/v1_201704280925/S1579212917300058/v1_201704280925/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1579212917301337"
    "issn" => "15792129"
    "doi" => "10.1016/j.arbr.2017.01.017"
    "estado" => "S300"
    "fechaPublicacion" => "2017-05-01"
    "aid" => "1556"
    "copyright" => "SEPAR"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Arch Bronconeumol. 2017;53:233-4"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 1566
      "formatos" => array:3 [
        "EPUB" => 143
        "HTML" => 1034
        "PDF" => 389
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "Emerging Therapies in Severe Eosinophilic Asthma"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "233"
          "paginaFinal" => "234"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Nuevas terapias para el asma eosinof&#237;lica grave"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Pee Hwee Pang, Christopher E&#46; Brightling"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Pee Hwee"
              "apellidos" => "Pang"
            ]
            1 => array:2 [
              "nombre" => "Christopher E&#46;"
              "apellidos" => "Brightling"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0300289617300339"
        "doi" => "10.1016/j.arbres.2017.01.012"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617300339?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301337?idApp=UINPBA00003Z"
    "url" => "/15792129/0000005300000005/v1_201704280925/S1579212917301337/v1_201704280925/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Novelties in the Treatment of Pulmonary Hypertension"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "235"
        "paginaFinal" => "236"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Jason Weatherald, Yu Taniguchi, Marc Humbert"
        "autores" => array:3 [
          0 => array:3 [
            "nombre" => "Jason"
            "apellidos" => "Weatherald"
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Yu"
            "apellidos" => "Taniguchi"
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Marc"
            "apellidos" => "Humbert"
            "email" => array:1 [
              0 => "marc&#46;humbert&#64;aphp&#46;fr"
            ]
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => "Facult&#233; de M&#233;decine&#44; Universit&#233; Paris-Sud&#44; Universit&#233; Paris-Saclay&#44; Le Kremlin-Bic&#234;tre&#44; France"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Service de Pneumologie&#44; Assistance Publique-H&#244;pitaux de Paris&#44; Le Kremlin-Bic&#234;tre&#44; France"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "INSERM UMR&#95;S 999&#44; H&#244;pital Marie Lannelongue&#44; Le Plessis Robinson&#44; France"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Department of Medicine&#44; Division of Respirology&#44; University of Calgary&#44; Calgary&#44; Canada"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "Division of Cardiovascular Medicine&#44; Department of Internal Medicine&#44; Kobe University Graduate School of Medicine&#44; Kobe&#44; Japan"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Novedades en el tratamiento de la hipertensi&#243;n pulmonar"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Pulmonary arterial hypertension &#40;PAH&#41; and chronic thromboembolic pulmonary hypertension &#40;CTEPH&#41; are progressive diseases of the pulmonary circulation that lead to right heart failure&#46; Exciting recent advances have improved prognosis&#44; however PAH and CTEPH remain disabling and life limiting conditions&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Currently approved medical therapies improve functional capacity&#44; hemodynamics and delay clinical worsening by targeting the 3 main pathobiologic pathways&#58; prostacyclin&#44; endothelin&#44; and nitric oxide&#46; Recently&#44; several new agents targeting the classic PAH pathways have been developed for the treatment of pulmonary hypertension&#46; However&#44; a targeted treatment that delays or reverses vascular remodeling remains elusive&#46; Recent attempts to specifically inhibit or reverse vascular proliferation in PAH with imatinib&#44; a tyrosine kinase inhibitor&#44; were disappointing because of the high dropout rate due to adverse events &#40;over 30&#37;&#41; and the high incidence of subdural hematoma&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Selexipag is a new oral selective PGI2 receptor agonist that targets the prostacyclin pathway&#46; In the placebo-controlled GRIPHON study of 1156 patients with PAH&#44; selexipag reduced the risk of death or PAH-related complications by 40&#37;&#44; an effect that was primarily driven by a reduction in disease progression and hospitalization for PAH&#59; mortality was similar in both study groups&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Importantly though&#44; the treatment effect was consistent across treatment na&#239;ve patients and those receiving background phosphodiesterase type 5 &#40;PDE5&#41; inhibitors and&#47;or endothelin receptor antagonists&#46; Unlike PDE5 inhibitors&#44; riociguat acts by directly stimulating soluble guanylate cyclase&#44; independent of nitric oxide availability&#46; In recently published long-term extension studies of randomized controlled trials of PAH patients &#40;PATENT-2&#41;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> and CTEPH patients &#40;CHEST-2&#41;&#44;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> riociguat was well tolerated with sustained improvements in functional capacity and 6-minute walk distance in both patient populations&#46; Riociguat is also the only targeted medication currently approved for treating CTEPH&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Combination therapy in PAH has gained momentum&#44; however there remains some debate on the optimal strategy&#58; upfront versus sequential addition of therapies&#46; The COMPASS-2 study evaluated a strategy of sequentially adding bosentan to patients on background sildenafil for at least 12 weeks&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> This was a negative study with regards to the primary endpoint&#59; however&#44; a long recruitment period and high dropout rate resulted in the study being underpowered&#46; In contrast&#44; the AMBITION trial evaluated an upfront combination approach using ambrisentan and tadalafil versus monotherapy in treatment na&#239;ve patients&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> There was a 50&#37; reduction in the primary endpoint with initial combination therapy&#44; driven by a reduction in hospitalization for PAH&#46; Based on the results of AMBITION&#44; initial combination therapy with ambrisentan and tadalafil was given a class IB recommendation in the recent European guidelines&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> This recommendation is supported by a recent analysis from the French registry showing a 3-year survival of 84&#37; in patients treated with initial dual oral combination therapy compared to an expected historical 3-year survival of 66&#37;&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Although pulmonary endarterectomy remains the gold standard treatment for eligible CTEPH patients&#44; many are not eligible for surgery due to inaccessible distal thromboembolic disease or comorbidities&#46; Balloon pulmonary angioplasty &#40;BPA&#41;&#44; an endovascular procedure to widen narrowed or obstructed pulmonary arteries&#44; has emerged as an exciting alternative treatment option for patients with non-operable CTEPH or patients with persistent pulmonary hypertension after endarterectomy&#46; The first series published in 2001 demonstrated a reduction in mean pulmonary artery pressure &#40;mPAP&#41; of 9<span class="elsevierStyleHsp" style=""></span>mmHg&#44; but reported a 5&#46;6&#37; rate of in-hospital death&#46; Following refinements in the technique&#44; several reports&#44; mainly from Japan&#44; now support the efficacy and safety of BPA&#46; The hemodynamic benefits were summarized in a recent review article&#44; which reported an overall reduction in mPAP of 12&#8211;21<span class="elsevierStyleHsp" style=""></span>mmHg from baseline&#44; and a mortality rate of 0&#46;0&#8211;3&#46;4&#37; after 2&#8211;5 angioplasty sessions&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> A recent Japanese study reported the results of 170 patients who underwent BPA over a 7 year period&#46; They found sustained hemodynamic improvements&#44; almost to within the normal range&#44; in mPAP and pulmonary vascular resistance up to 3&#46;5 years after BPA&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> In this series&#44; the 1&#44; 3&#44; and 5-year survival rates were 98&#46;7&#37;&#44; 98&#46;0&#37;&#44; and 95&#46;5&#37;&#44; however 1 death was attributed to multi-organ failure secondary to pulmonary artery injury&#44; a known complication of BPA&#46; Severe and fatal complications&#44; including reperfusion edema or pulmonary artery perforation&#44; may be minimized as the learning curve progresses&#46; Although the indications and limitations have not been fully established&#44; BPA has the potential to become a key treatment strategy for patients with non-operable CTEPH&#46; An open-label&#44; randomized controlled trial comparing BPA to riociguat in non-operable CTEPH patients is currently underway in France&#44; with a primary endpoint of change in pulmonary vascular resistance at 26 weeks &#40;RACE trial&#44; <a href="ctgov:NCT02634203">NCT02634203</a>&#41;&#46; This trial may help clarify the relative place of BPA and riociguat in a CTEPH treatment algorithm&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">In conclusion&#44; there have been important advances in the treatment of PAH and CTEPH over the past few years&#46; However&#44; PAH remains a progressive and fatal disease in most cases&#46; Until the development of effective therapies that can slow or reverse vascular proliferation&#44; inflammation and remodeling&#44; parenteral prostanoids&#44; combination therapy and lung transplantation are the only life-prolonging therapies&#46; Patients with CTEPH now benefit from several therapeutic options including possible combinations of surgery&#44; medical therapy and BPA&#46; Riociguat and balloon pulmonary angioplasty are new effective options for CTEPH that result in significant clinical improvements for non-operable patients and those with persistent pulmonary hypertension after endarterectomy&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interests</span><p id="par0030" class="elsevierStylePara elsevierViewall">Dr&#46; Humbert reports personal fees from Actelion Pharmaceuticals Ltd&#46;&#44; grants and personal fees from Bayer&#44; grants and personal fees from GSK&#44; personal fees from Pfizer&#59; and personal fees from Novartis&#44; outside the submitted work&#46; Dr&#46; Weatherald has received grants from the European Respiratory Society and Canadian Thoracic Society&#59; personal fees and non-financial support from Actelion and Bayer&#44; outside the submitted work&#46; Dr&#46; Taniguchi has no conflict of interest to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflict of interests"
        ]
        1 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term safety and efficacy of imatinib in pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;E&#46; Frost"
                            1 => "R&#46;J&#46; Barst"
                            2 => "M&#46;M&#46; Hoeper"
                            3 => "H&#46;-J&#46; Chang"
                            4 => "R&#46;P&#46; Frantz"
                            5 => "Y&#46; Fukumoto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.healun.2015.05.025"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Heart Lung Transplant"
                        "fecha" => "2015"
                        "volumen" => "34"
                        "paginaInicial" => "1366"
                        "paginaFinal" => "1375"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26210752"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Selexipag for the treatment of pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "O&#46; Sitbon"
                            1 => "R&#46; Channick"
                            2 => "K&#46;M&#46; Chin"
                            3 => "A&#46; Frey"
                            4 => "S&#46; Gaine"
                            5 => "N&#46; Galie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1503184"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2015"
                        "volumen" => "373"
                        "paginaInicial" => "2522"
                        "paginaFinal" => "2533"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26699168"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Riociguat for the treatment of pulmonary arterial hypertension&#58; a long-term extension study &#40;PATENT-2&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46;J&#46; Rubin"
                            1 => "N&#46; Galie"
                            2 => "F&#46; Grimminger"
                            3 => "E&#46; Gr&#252;nig"
                            4 => "M&#46; Humbert"
                            5 => "Z&#46;-C&#46; Jing"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00090614"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2015"
                        "volumen" => "45"
                        "paginaInicial" => "1303"
                        "paginaFinal" => "1313"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25614164"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Riociguat for the treatment of chronic thromboembolic pulmonary hypertension&#58; a long-term extension study &#40;CHEST-2&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Simonneau"
                            1 => "A&#46;M&#46; D&#8217;Armini"
                            2 => "H&#46;-A&#46; Ghofrani"
                            3 => "F&#46; Grimminger"
                            4 => "M&#46;M&#46; Hoeper"
                            5 => "P&#46; Jansa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00087114"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2015"
                        "volumen" => "45"
                        "paginaInicial" => "1293"
                        "paginaFinal" => "1302"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25395036"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46; McLaughlin"
                            1 => "R&#46;N&#46; Channick"
                            2 => "H&#46;-A&#46; Ghofrani"
                            3 => "J&#46;-C&#46; Lemari&#233;"
                            4 => "R&#46; Naeije"
                            5 => "M&#46; Packer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/13993003.02044-2014"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2015"
                        "volumen" => "46"
                        "paginaInicial" => "405"
                        "paginaFinal" => "413"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26113687"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "AMBITION Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Galie"
                            1 => "J&#46;A&#46; Barber&#224;"
                            2 => "A&#46;E&#46; Frost"
                            3 => "H&#46;-A&#46; Ghofrani"
                            4 => "M&#46;M&#46; Hoeper"
                            5 => "V&#46;V&#46; McLaughlin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1413687"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2015"
                        "volumen" => "373"
                        "paginaInicial" => "834"
                        "paginaFinal" => "844"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26308684"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2015 ESC&#47;ERS Guidelines for the diagnosis and treatment of pulmonary hypertension&#58; The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology &#40;ESC&#41; and the European Respiratory Society &#40;ERS&#41;&#58; Endorsed by&#58; Association for European Paediatric and Congenital Cardiology &#40;AEPC&#41;&#44; International Society for Heart and Lung Transplantation &#40;ISHLT&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Galie"
                            1 => "M&#46; Humbert"
                            2 => "J&#46;-L&#46; Vachi&#233;ry"
                            3 => "S&#46; Gibbs"
                            4 => "I&#46; Lang"
                            5 => "A&#46; Torbicki"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/13993003.01032-2015"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2015"
                        "volumen" => "46"
                        "paginaInicial" => "903"
                        "paginaFinal" => "975"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26318161"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Initial dual oral combination therapy in pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "O&#46; Sitbon"
                            1 => "C&#46; Sattler"
                            2 => "L&#46; Bertoletti"
                            3 => "L&#46; Savale"
                            4 => "V&#46; Cottin"
                            5 => "X&#46; Ja&#239;s"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/13993003.02043-2015"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2016"
                        "volumen" => "47"
                        "paginaInicial" => "1727"
                        "paginaFinal" => "1736"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26989105"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Endovascular treatment for chronic pulmonary hypertension&#58; a focus on angioplasty for chronic thromboembolic pulmonary hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Satoh"
                            1 => "M&#46; Kataoka"
                            2 => "T&#46; Inami"
                            3 => "H&#46; Ishiguro"
                            4 => "R&#46; Yanagisawa"
                            5 => "N&#46; Shimura"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/14779072.2016.1208083"
                      "Revista" => array:6 [
                        "tituloSerie" => "Expert Rev Cardiovasc Ther"
                        "fecha" => "2016"
                        "volumen" => "14"
                        "paginaInicial" => "1089"
                        "paginaFinal" => "1094"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27367530"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Inami"
                            1 => "M&#46; Kataoka"
                            2 => "R&#46; Yanagisawa"
                            3 => "H&#46; Ishiguro"
                            4 => "N&#46; Shimura"
                            5 => "K&#46; Fukuda"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.116.024201"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2016"
                        "volumen" => "134"
                        "paginaInicial" => "2030"
                        "paginaFinal" => "2032"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27956405"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:3 [
        "titulo" => "Acknowledgements"
        "texto" => "<p id="par0035" class="elsevierStylePara elsevierViewall">Dr&#46; Jason Weatherald is the recipient of a joint ERS&#47;CTS Fellowship &#40;LTRF 2015-4780&#41;&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15792129/0000005300000005/v1_201704280925/S1579212917301349/v1_201704280925/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "46447"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005300000005/v1_201704280925/S1579212917301349/v1_201704280925/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301349?idApp=UINPBA00003Z"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Editorial
Novelties in the Treatment of Pulmonary Hypertension
Novedades en el tratamiento de la hipertensión pulmonar
Jason Weatheralda,b,c,d, Yu Taniguchia,b,c,e, Marc Humberta,b,c,
Corresponding author
marc.humbert@aphp.fr

Corresponding author.
a Faculté de Médecine, Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France
b Service de Pneumologie, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France
c INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France
d Department of Medicine, Division of Respirology, University of Calgary, Calgary, Canada
e Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
Read
3522
Times
was read the article
1602
Total PDF
1920
Total HTML
Share statistics
 array:24 [
  "pii" => "S1579212917301349"
  "issn" => "15792129"
  "doi" => "10.1016/j.arbr.2017.01.018"
  "estado" => "S300"
  "fechaPublicacion" => "2017-05-01"
  "aid" => "1563"
  "copyright" => "SEPAR"
  "copyrightAnyo" => "2017"
  "documento" => "article"
  "crossmark" => 1
  "subdocumento" => "sco"
  "cita" => "Arch Bronconeumol. 2017;53:235-6"
  "abierto" => array:3 [
    "ES" => false
    "ES2" => false
    "LATM" => false
  ]
  "gratuito" => false
  "lecturas" => array:2 [
    "total" => 1013
    "formatos" => array:3 [
      "EPUB" => 140
      "HTML" => 548
      "PDF" => 325
    ]
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0300289617300418"
      "issn" => "03002896"
      "doi" => "10.1016/j.arbres.2017.01.016"
      "estado" => "S300"
      "fechaPublicacion" => "2017-05-01"
      "aid" => "1563"
      "copyright" => "SEPAR"
      "documento" => "article"
      "crossmark" => 1
      "subdocumento" => "sco"
      "cita" => "Arch Bronconeumol. 2017;53:235-6"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2193
        "formatos" => array:3 [
          "EPUB" => 154
          "HTML" => 1479
          "PDF" => 560
        ]
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
        "titulo" => "Novelties in the Treatment of Pulmonary Hypertension"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "235"
            "paginaFinal" => "236"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "es" => array:1 [
            "titulo" => "Novedades en el tratamiento de la hipertensi&#243;n pulmonar"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Jason Weatherald, Yu Taniguchi, Marc Humbert"
            "autores" => array:3 [
              0 => array:2 [
                "nombre" => "Jason"
                "apellidos" => "Weatherald"
              ]
              1 => array:2 [
                "nombre" => "Yu"
                "apellidos" => "Taniguchi"
              ]
              2 => array:2 [
                "nombre" => "Marc"
                "apellidos" => "Humbert"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1579212917301349"
          "doi" => "10.1016/j.arbr.2017.01.018"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => false
            "ES2" => false
            "LATM" => false
          ]
          "gratuito" => false
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301349?idApp=UINPBA00003Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617300418?idApp=UINPBA00003Z"
      "url" => "/03002896/0000005300000005/v1_201704280943/S0300289617300418/v1_201704280943/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1579212917300058"
    "issn" => "15792129"
    "doi" => "10.1016/j.arbr.2017.01.002"
    "estado" => "S300"
    "fechaPublicacion" => "2017-05-01"
    "aid" => "1525"
    "copyright" => "SEPAR"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "fla"
    "cita" => "Arch Bronconeumol. 2017;53:237-44"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 2730
      "formatos" => array:3 [
        "EPUB" => 153
        "HTML" => 1929
        "PDF" => 648
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
      "titulo" => "Changes in Ventilatory Response to Exercise in Trained Athletes&#58; Respiratory Physiological Benefits Beyond Cardiovascular Performance"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "237"
          "paginaFinal" => "244"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Cambios en la respuesta ventilatoria al esfuerzo en deportistas entrenados&#58; efectos beneficiosos sobre la fisiolog&#237;a respiratoria m&#225;s all&#225; del rendimiento cardiovascular"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0010"
          "etiqueta" => "Fig&#46; 2"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr2.jpeg"
              "Alto" => 1197
              "Ancho" => 1578
              "Tamanyo" => 73205
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Tidal volume &#40;V<span class="elsevierStyleInf">T</span>&#41; is plotted as a function of ventilation &#40;V<span class="elsevierStyleInf">E</span>&#41; in response to symptom-limited treadmill exercise in all study subjects before &#40;filled circles&#41; and after &#40;open circles&#41; 8 months of training and competition&#46; The graph shows mean values at baseline &#40;starting at 8<span class="elsevierStyleHsp" style=""></span>km&#47;h&#41;&#44; iso-speed &#40;16<span class="elsevierStyleHsp" style=""></span>km&#47;h&#41;&#44; V<span class="elsevierStyleInf">T</span>&#47;V<span class="elsevierStyleInf">E</span> inflection 1&#44; V<span class="elsevierStyleInf">T</span>&#47;V<span class="elsevierStyleInf">E</span> inflection 2 and peak exercise&#46; <span class="elsevierStyleItalic">P</span> values before vs after training and competition at the same measurement point are shown in <a class="elsevierStyleCrossRefs" href="#tbl0010">Tables 2 and 3</a>&#46; <span class="elsevierStyleItalic">Abbreviations</span>&#58; L&#44; liters&#59; min&#44; minutes&#59; km&#44; kilometers&#59; h&#44; hours&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Adriano Di Paco, Bruno-Pierre Dub&#233;, Pierantonio Laveneziana"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Adriano"
              "apellidos" => "Di Paco"
            ]
            1 => array:2 [
              "nombre" => "Bruno-Pierre"
              "apellidos" => "Dub&#233;"
            ]
            2 => array:2 [
              "nombre" => "Pierantonio"
              "apellidos" => "Laveneziana"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0300289616303556"
        "doi" => "10.1016/j.arbres.2016.11.023"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616303556?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917300058?idApp=UINPBA00003Z"
    "url" => "/15792129/0000005300000005/v1_201704280925/S1579212917300058/v1_201704280925/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1579212917301337"
    "issn" => "15792129"
    "doi" => "10.1016/j.arbr.2017.01.017"
    "estado" => "S300"
    "fechaPublicacion" => "2017-05-01"
    "aid" => "1556"
    "copyright" => "SEPAR"
    "documento" => "article"
    "crossmark" => 1
    "subdocumento" => "sco"
    "cita" => "Arch Bronconeumol. 2017;53:233-4"
    "abierto" => array:3 [
      "ES" => false
      "ES2" => false
      "LATM" => false
    ]
    "gratuito" => false
    "lecturas" => array:2 [
      "total" => 1566
      "formatos" => array:3 [
        "EPUB" => 143
        "HTML" => 1034
        "PDF" => 389
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
      "titulo" => "Emerging Therapies in Severe Eosinophilic Asthma"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "233"
          "paginaFinal" => "234"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Nuevas terapias para el asma eosinof&#237;lica grave"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Pee Hwee Pang, Christopher E&#46; Brightling"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "Pee Hwee"
              "apellidos" => "Pang"
            ]
            1 => array:2 [
              "nombre" => "Christopher E&#46;"
              "apellidos" => "Brightling"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0300289617300339"
        "doi" => "10.1016/j.arbres.2017.01.012"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617300339?idApp=UINPBA00003Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301337?idApp=UINPBA00003Z"
    "url" => "/15792129/0000005300000005/v1_201704280925/S1579212917301337/v1_201704280925/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
    "titulo" => "Novelties in the Treatment of Pulmonary Hypertension"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "235"
        "paginaFinal" => "236"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Jason Weatherald, Yu Taniguchi, Marc Humbert"
        "autores" => array:3 [
          0 => array:3 [
            "nombre" => "Jason"
            "apellidos" => "Weatherald"
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "aff0020"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Yu"
            "apellidos" => "Taniguchi"
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">e</span>"
                "identificador" => "aff0025"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Marc"
            "apellidos" => "Humbert"
            "email" => array:1 [
              0 => "marc&#46;humbert&#64;aphp&#46;fr"
            ]
            "referencia" => array:4 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              3 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:5 [
          0 => array:3 [
            "entidad" => "Facult&#233; de M&#233;decine&#44; Universit&#233; Paris-Sud&#44; Universit&#233; Paris-Saclay&#44; Le Kremlin-Bic&#234;tre&#44; France"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Service de Pneumologie&#44; Assistance Publique-H&#244;pitaux de Paris&#44; Le Kremlin-Bic&#234;tre&#44; France"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "INSERM UMR&#95;S 999&#44; H&#244;pital Marie Lannelongue&#44; Le Plessis Robinson&#44; France"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
          3 => array:3 [
            "entidad" => "Department of Medicine&#44; Division of Respirology&#44; University of Calgary&#44; Calgary&#44; Canada"
            "etiqueta" => "d"
            "identificador" => "aff0020"
          ]
          4 => array:3 [
            "entidad" => "Division of Cardiovascular Medicine&#44; Department of Internal Medicine&#44; Kobe University Graduate School of Medicine&#44; Kobe&#44; Japan"
            "etiqueta" => "e"
            "identificador" => "aff0025"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Novedades en el tratamiento de la hipertensi&#243;n pulmonar"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Pulmonary arterial hypertension &#40;PAH&#41; and chronic thromboembolic pulmonary hypertension &#40;CTEPH&#41; are progressive diseases of the pulmonary circulation that lead to right heart failure&#46; Exciting recent advances have improved prognosis&#44; however PAH and CTEPH remain disabling and life limiting conditions&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Currently approved medical therapies improve functional capacity&#44; hemodynamics and delay clinical worsening by targeting the 3 main pathobiologic pathways&#58; prostacyclin&#44; endothelin&#44; and nitric oxide&#46; Recently&#44; several new agents targeting the classic PAH pathways have been developed for the treatment of pulmonary hypertension&#46; However&#44; a targeted treatment that delays or reverses vascular remodeling remains elusive&#46; Recent attempts to specifically inhibit or reverse vascular proliferation in PAH with imatinib&#44; a tyrosine kinase inhibitor&#44; were disappointing because of the high dropout rate due to adverse events &#40;over 30&#37;&#41; and the high incidence of subdural hematoma&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Selexipag is a new oral selective PGI2 receptor agonist that targets the prostacyclin pathway&#46; In the placebo-controlled GRIPHON study of 1156 patients with PAH&#44; selexipag reduced the risk of death or PAH-related complications by 40&#37;&#44; an effect that was primarily driven by a reduction in disease progression and hospitalization for PAH&#59; mortality was similar in both study groups&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Importantly though&#44; the treatment effect was consistent across treatment na&#239;ve patients and those receiving background phosphodiesterase type 5 &#40;PDE5&#41; inhibitors and&#47;or endothelin receptor antagonists&#46; Unlike PDE5 inhibitors&#44; riociguat acts by directly stimulating soluble guanylate cyclase&#44; independent of nitric oxide availability&#46; In recently published long-term extension studies of randomized controlled trials of PAH patients &#40;PATENT-2&#41;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> and CTEPH patients &#40;CHEST-2&#41;&#44;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a> riociguat was well tolerated with sustained improvements in functional capacity and 6-minute walk distance in both patient populations&#46; Riociguat is also the only targeted medication currently approved for treating CTEPH&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Combination therapy in PAH has gained momentum&#44; however there remains some debate on the optimal strategy&#58; upfront versus sequential addition of therapies&#46; The COMPASS-2 study evaluated a strategy of sequentially adding bosentan to patients on background sildenafil for at least 12 weeks&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> This was a negative study with regards to the primary endpoint&#59; however&#44; a long recruitment period and high dropout rate resulted in the study being underpowered&#46; In contrast&#44; the AMBITION trial evaluated an upfront combination approach using ambrisentan and tadalafil versus monotherapy in treatment na&#239;ve patients&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> There was a 50&#37; reduction in the primary endpoint with initial combination therapy&#44; driven by a reduction in hospitalization for PAH&#46; Based on the results of AMBITION&#44; initial combination therapy with ambrisentan and tadalafil was given a class IB recommendation in the recent European guidelines&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a> This recommendation is supported by a recent analysis from the French registry showing a 3-year survival of 84&#37; in patients treated with initial dual oral combination therapy compared to an expected historical 3-year survival of 66&#37;&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Although pulmonary endarterectomy remains the gold standard treatment for eligible CTEPH patients&#44; many are not eligible for surgery due to inaccessible distal thromboembolic disease or comorbidities&#46; Balloon pulmonary angioplasty &#40;BPA&#41;&#44; an endovascular procedure to widen narrowed or obstructed pulmonary arteries&#44; has emerged as an exciting alternative treatment option for patients with non-operable CTEPH or patients with persistent pulmonary hypertension after endarterectomy&#46; The first series published in 2001 demonstrated a reduction in mean pulmonary artery pressure &#40;mPAP&#41; of 9<span class="elsevierStyleHsp" style=""></span>mmHg&#44; but reported a 5&#46;6&#37; rate of in-hospital death&#46; Following refinements in the technique&#44; several reports&#44; mainly from Japan&#44; now support the efficacy and safety of BPA&#46; The hemodynamic benefits were summarized in a recent review article&#44; which reported an overall reduction in mPAP of 12&#8211;21<span class="elsevierStyleHsp" style=""></span>mmHg from baseline&#44; and a mortality rate of 0&#46;0&#8211;3&#46;4&#37; after 2&#8211;5 angioplasty sessions&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> A recent Japanese study reported the results of 170 patients who underwent BPA over a 7 year period&#46; They found sustained hemodynamic improvements&#44; almost to within the normal range&#44; in mPAP and pulmonary vascular resistance up to 3&#46;5 years after BPA&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> In this series&#44; the 1&#44; 3&#44; and 5-year survival rates were 98&#46;7&#37;&#44; 98&#46;0&#37;&#44; and 95&#46;5&#37;&#44; however 1 death was attributed to multi-organ failure secondary to pulmonary artery injury&#44; a known complication of BPA&#46; Severe and fatal complications&#44; including reperfusion edema or pulmonary artery perforation&#44; may be minimized as the learning curve progresses&#46; Although the indications and limitations have not been fully established&#44; BPA has the potential to become a key treatment strategy for patients with non-operable CTEPH&#46; An open-label&#44; randomized controlled trial comparing BPA to riociguat in non-operable CTEPH patients is currently underway in France&#44; with a primary endpoint of change in pulmonary vascular resistance at 26 weeks &#40;RACE trial&#44; <a href="ctgov:NCT02634203">NCT02634203</a>&#41;&#46; This trial may help clarify the relative place of BPA and riociguat in a CTEPH treatment algorithm&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">In conclusion&#44; there have been important advances in the treatment of PAH and CTEPH over the past few years&#46; However&#44; PAH remains a progressive and fatal disease in most cases&#46; Until the development of effective therapies that can slow or reverse vascular proliferation&#44; inflammation and remodeling&#44; parenteral prostanoids&#44; combination therapy and lung transplantation are the only life-prolonging therapies&#46; Patients with CTEPH now benefit from several therapeutic options including possible combinations of surgery&#44; medical therapy and BPA&#46; Riociguat and balloon pulmonary angioplasty are new effective options for CTEPH that result in significant clinical improvements for non-operable patients and those with persistent pulmonary hypertension after endarterectomy&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interests</span><p id="par0030" class="elsevierStylePara elsevierViewall">Dr&#46; Humbert reports personal fees from Actelion Pharmaceuticals Ltd&#46;&#44; grants and personal fees from Bayer&#44; grants and personal fees from GSK&#44; personal fees from Pfizer&#59; and personal fees from Novartis&#44; outside the submitted work&#46; Dr&#46; Weatherald has received grants from the European Respiratory Society and Canadian Thoracic Society&#59; personal fees and non-financial support from Actelion and Bayer&#44; outside the submitted work&#46; Dr&#46; Taniguchi has no conflict of interest to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:2 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflict of interests"
        ]
        1 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term safety and efficacy of imatinib in pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46;E&#46; Frost"
                            1 => "R&#46;J&#46; Barst"
                            2 => "M&#46;M&#46; Hoeper"
                            3 => "H&#46;-J&#46; Chang"
                            4 => "R&#46;P&#46; Frantz"
                            5 => "Y&#46; Fukumoto"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.healun.2015.05.025"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Heart Lung Transplant"
                        "fecha" => "2015"
                        "volumen" => "34"
                        "paginaInicial" => "1366"
                        "paginaFinal" => "1375"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26210752"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Selexipag for the treatment of pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "O&#46; Sitbon"
                            1 => "R&#46; Channick"
                            2 => "K&#46;M&#46; Chin"
                            3 => "A&#46; Frey"
                            4 => "S&#46; Gaine"
                            5 => "N&#46; Galie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1503184"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2015"
                        "volumen" => "373"
                        "paginaInicial" => "2522"
                        "paginaFinal" => "2533"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26699168"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Riociguat for the treatment of pulmonary arterial hypertension&#58; a long-term extension study &#40;PATENT-2&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "L&#46;J&#46; Rubin"
                            1 => "N&#46; Galie"
                            2 => "F&#46; Grimminger"
                            3 => "E&#46; Gr&#252;nig"
                            4 => "M&#46; Humbert"
                            5 => "Z&#46;-C&#46; Jing"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00090614"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2015"
                        "volumen" => "45"
                        "paginaInicial" => "1303"
                        "paginaFinal" => "1313"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25614164"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Riociguat for the treatment of chronic thromboembolic pulmonary hypertension&#58; a long-term extension study &#40;CHEST-2&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "G&#46; Simonneau"
                            1 => "A&#46;M&#46; D&#8217;Armini"
                            2 => "H&#46;-A&#46; Ghofrani"
                            3 => "F&#46; Grimminger"
                            4 => "M&#46;M&#46; Hoeper"
                            5 => "P&#46; Jansa"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/09031936.00087114"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2015"
                        "volumen" => "45"
                        "paginaInicial" => "1293"
                        "paginaFinal" => "1302"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25395036"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "V&#46; McLaughlin"
                            1 => "R&#46;N&#46; Channick"
                            2 => "H&#46;-A&#46; Ghofrani"
                            3 => "J&#46;-C&#46; Lemari&#233;"
                            4 => "R&#46; Naeije"
                            5 => "M&#46; Packer"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/13993003.02044-2014"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2015"
                        "volumen" => "46"
                        "paginaInicial" => "405"
                        "paginaFinal" => "413"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26113687"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "AMBITION Investigators"
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Galie"
                            1 => "J&#46;A&#46; Barber&#224;"
                            2 => "A&#46;E&#46; Frost"
                            3 => "H&#46;-A&#46; Ghofrani"
                            4 => "M&#46;M&#46; Hoeper"
                            5 => "V&#46;V&#46; McLaughlin"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1413687"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2015"
                        "volumen" => "373"
                        "paginaInicial" => "834"
                        "paginaFinal" => "844"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26308684"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "2015 ESC&#47;ERS Guidelines for the diagnosis and treatment of pulmonary hypertension&#58; The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology &#40;ESC&#41; and the European Respiratory Society &#40;ERS&#41;&#58; Endorsed by&#58; Association for European Paediatric and Congenital Cardiology &#40;AEPC&#41;&#44; International Society for Heart and Lung Transplantation &#40;ISHLT&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "N&#46; Galie"
                            1 => "M&#46; Humbert"
                            2 => "J&#46;-L&#46; Vachi&#233;ry"
                            3 => "S&#46; Gibbs"
                            4 => "I&#46; Lang"
                            5 => "A&#46; Torbicki"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/13993003.01032-2015"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2015"
                        "volumen" => "46"
                        "paginaInicial" => "903"
                        "paginaFinal" => "975"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26318161"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Initial dual oral combination therapy in pulmonary arterial hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "O&#46; Sitbon"
                            1 => "C&#46; Sattler"
                            2 => "L&#46; Bertoletti"
                            3 => "L&#46; Savale"
                            4 => "V&#46; Cottin"
                            5 => "X&#46; Ja&#239;s"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1183/13993003.02043-2015"
                      "Revista" => array:6 [
                        "tituloSerie" => "Eur Respir J"
                        "fecha" => "2016"
                        "volumen" => "47"
                        "paginaInicial" => "1727"
                        "paginaFinal" => "1736"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26989105"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Endovascular treatment for chronic pulmonary hypertension&#58; a focus on angioplasty for chronic thromboembolic pulmonary hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Satoh"
                            1 => "M&#46; Kataoka"
                            2 => "T&#46; Inami"
                            3 => "H&#46; Ishiguro"
                            4 => "R&#46; Yanagisawa"
                            5 => "N&#46; Shimura"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/14779072.2016.1208083"
                      "Revista" => array:6 [
                        "tituloSerie" => "Expert Rev Cardiovasc Ther"
                        "fecha" => "2016"
                        "volumen" => "14"
                        "paginaInicial" => "1089"
                        "paginaFinal" => "1094"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27367530"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term outcomes after percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "T&#46; Inami"
                            1 => "M&#46; Kataoka"
                            2 => "R&#46; Yanagisawa"
                            3 => "H&#46; Ishiguro"
                            4 => "N&#46; Shimura"
                            5 => "K&#46; Fukuda"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1161/CIRCULATIONAHA.116.024201"
                      "Revista" => array:6 [
                        "tituloSerie" => "Circulation"
                        "fecha" => "2016"
                        "volumen" => "134"
                        "paginaInicial" => "2030"
                        "paginaFinal" => "2032"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27956405"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
    "agradecimientos" => array:1 [
      0 => array:3 [
        "titulo" => "Acknowledgements"
        "texto" => "<p id="par0035" class="elsevierStylePara elsevierViewall">Dr&#46; Jason Weatherald is the recipient of a joint ERS&#47;CTS Fellowship &#40;LTRF 2015-4780&#41;&#46;</p>"
        "vista" => "all"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15792129/0000005300000005/v1_201704280925/S1579212917301349/v1_201704280925/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "46447"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005300000005/v1_201704280925/S1579212917301349/v1_201704280925/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212917301349?idApp=UINPBA00003Z"
]
Article information
ISSN: 15792129
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 1 3 4
2024 October 30 21 51
2024 September 19 18 37
2024 August 42 38 80
2024 July 29 24 53
2024 June 36 19 55
2024 May 65 27 92
2024 April 27 32 59
2024 March 74 21 95
2024 February 61 20 81
2023 March 7 1 8
2023 February 35 21 56
2023 January 23 40 63
2022 December 26 45 71
2022 November 41 23 64
2022 October 30 35 65
2022 September 25 24 49
2022 August 33 40 73
2022 July 26 43 69
2022 June 24 37 61
2022 May 27 37 64
2022 April 24 30 54
2022 March 35 35 70
2022 February 28 19 47
2022 January 26 35 61
2021 December 30 42 72
2021 November 34 43 77
2021 October 35 43 78
2021 September 35 47 82
2021 August 24 29 53
2021 July 21 37 58
2021 June 29 32 61
2021 May 35 36 71
2021 April 65 71 136
2021 March 36 18 54
2021 February 28 23 51
2021 January 24 18 42
2020 December 26 18 44
2020 November 19 15 34
2020 October 20 20 40
2020 September 7 11 18
2020 August 25 8 33
2020 July 14 22 36
2020 June 10 11 21
2020 May 16 11 27
2020 April 24 17 41
2020 March 17 8 25
2020 February 13 22 35
2020 January 18 17 35
2019 December 16 14 30
2019 November 17 17 34
2019 October 24 19 43
2019 September 16 7 23
2019 August 21 12 33
2019 July 18 11 29
2019 June 10 12 22
2019 May 31 7 38
2019 April 28 26 54
2019 March 31 17 48
2019 February 19 19 38
2019 January 22 10 32
2018 December 15 17 32
2018 November 42 17 59
2018 October 27 17 44
2018 September 29 4 33
2018 May 12 1 13
2018 April 8 4 12
2018 March 12 5 17
2018 February 22 4 26
2018 January 11 4 15
2017 December 13 4 17
2017 November 14 2 16
2017 October 18 16 34
2017 September 24 13 37
2017 August 19 14 33
2017 July 1 1 2
2017 May 1 1 2
Show all

Follow this link to access the full text of the article

Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?